(Q53560892)

15 May 2018

title

Amelioration of steatohepatitis with pentoxifylline in a novel nonalcoholic steatohepatitis model induced by high-fat diet. (English)

1 reference

15 May 2018

0 references

1 reference

1

Mehmet Yalniz

1 reference

15 May 2018

Nalan Kuzu

3

Nalan Kuzu

1 reference

15 May 2018

Selman Celebi

4

Selman Celebi

1 reference

15 May 2018

Bilal Ustundag

6

Bilal Ustündağ

1 reference

15 May 2018

Kazim Sahin

8

Kazim Sahin

1 reference

15 May 2018

Hüseyin Ataseven

5

Hüseyin Ataseven

1 reference

15 May 2018

author name string

I Halil Bahçecioğlu

2

1 reference

15 May 2018

Ibrahim H Ozercan

7

1 reference

15 May 2018

publication date

6 April 2007

1 reference

15 May 2018

Digestive Diseases and Sciences

published in

1 reference

15 May 2018

volume

52

1 reference

15 May 2018

page(s)

2380-2386

1 reference

15 May 2018

issue

9

1 reference

15 May 2018

https://scigraph.springernature.com/pub.10.1007/s10620-006-9194-1

exact match

0 references

cites work

Nonalcoholic fatty liver disease

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-006-9194-1

Inhibition of endogenous TNF formation by pentoxifylline

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS10620-006-9194-1

Pentoxifylline attenuates steatohepatitis induced by the methionine choline deficient diet

21 January 2018

1 reference

12 December 2020

Dietary choline restriction causes complex I dysfunction and increased H(2)O(2) generation in liver mitochondria.

1 reference

12 December 2020

Assay for blood plasma or serum

1 reference

12 December 2020

1 reference

12 December 2020

TNF-alpha and leptin in experimental liver fibrosis models induced by carbon tetrachloride and by common bile duct ligation

1 reference

12 December 2020

Augmented malondialdehyde production by platelets from patients with cerebrovascular disorders

1 reference

12 December 2020

Antioxidant and radical scavenging properties of 8-oxo derivatives of xanthine drugs pentoxifylline and lisofylline

1 reference

12 December 2020

Animal models of steatohepatitis

1 reference

12 December 2020

Gene expression of tumor necrosis factor alpha and TNF-receptors, p55 and p75, in nonalcoholic steatohepatitis patients

1 reference

12 December 2020

Cytokines in alcoholic and nonalcoholic steatohepatitis

1 reference

12 December 2020

Nonalcoholic steatohepatitis: what we know in the new millennium

1 reference

12 December 2020

Model of nonalcoholic steatohepatitis.

1 reference

12 December 2020

Hepatic steatosis in obese patients: clinical aspects and prognostic significance.

1 reference

12 December 2020

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

1 reference

12 December 2020

Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees

1 reference

12 December 2020

Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors

1 reference

12 December 2020

Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction

1 reference

12 December 2020

The role of small intestinal bacterial overgrowth, intestinal permeability, endotoxaemia, and tumour necrosis factor alpha in the pathogenesis of non-alcoholic steatohepatitis

1 reference

12 December 2020

The rapid induction of liver cell death in rats fed a choline-deficient methionine-low diet

1 reference

12 December 2020

Cellular and molecular regulation of tumor necrosis factor-alpha production by pentoxifylline

1 reference

12 December 2020

Transgenic mice lacking white fat: models for understanding human lipoatrophic diabetes.

1 reference

12 December 2020

10.1007/S10620-006-9194-1

Identifiers

DOI

1 reference

15 May 2018

PubMed ID

17415655

1 reference

15 May 2018